Rob Perry is currently the Head of Quality for PTC (Cell & Gene Therapy) at Roche, a role they have held since 2021. Previously, Perry served as the Quality Site Head at Roche Pharma Biotech in Penzberg, Germany from 2017 to 2019. They also held multiple quality assurance positions at Genentech from 2006 to 2017, advancing to the role of Director of Quality. Earlier in their career, Perry was a Senior Manager of Quality Assurance at Amgen from 2004 to 2006.
This person is not in the org chart
This person is not in any teams
This person is not in any offices